GovChime
AWARDPURCHASE ORDERSmall business

Purchase order NNX17CL73PLIGNAMED, LLC

Overview

Award facts

Net obligations
$125K
$125,000of $125K potential value
Period of performance
Jun 9, 2017 to Dec 8, 2017
Ended
Modifications
0
Latest action Jun 6, 2017
Contract type
Purchase order
PIID NNX17CL73P

Description of requirement

IGF::OT::IGF LIGNAMED, LLC IS A DRUG DEVELOPMENT COMPANY WITH A FAST TRACK STRATEGY TO APPROVAL OF LGM2605, AN ORAL SMALL MOLECULE FOR USE AS A RADIATION MITIGATING AGENT THAT REDUCES HARMFUL EFFECTS OF RADIATION EXPOSURE OF NORMAL TISSUES. LIGNAMED AIMS TO EVALUATE LGM2605 AS A MITIGATOR OF SPACE-RADIATION INDUCED VASCULAR DAMAGE. NASA MISSIONS TO MARS WILL EXPOSE ASTRONAUTS TO SOLAR AND GALACTIC COSMIC MIXED RADIATION INCLUDING LOW DOSE. AND PROTON RADIATION, BUT DATA IS LACKING ON THE BIOLOGICAL AND PHYSIOLOGICAL EFFECTS IN HUMANS OF THIS MIXED SOURCE RADIATION. RESEARCH ON SPACE RADIATION EFFECTS ON CELLULAR SYSTEMS, MOLECULAR TARGETS AND ULTIMATELY ORGAN SYSTEMS HAS IDENTIFIED POTENTIAL HARMFUL SHORT AND LONG-TERM EFFECTS ON THE HEALTH OF ASTRONAUTS. WORK AT THE UNIVERSITY OF PENNSYLVANIA IDENTIFIED DAMAGE TO LUNGS YEARS AFTER A SINGLE EXPOSURE TO LOW-DOSE GAMMA, 56FE, 28SI AND PROTON RADIATION EXPOSURE IN MICE. ACUTE AND CHRONIC RADIATION EFFECTS IN ORGANS ARE CLOSELY ASSOCIATED WITH VASCULAR DAMAGE AND DYSFUNCTION. MULTIPLE STUDIES HAVE CONFIRMED SINGLE SOURCE RADIATION SIDE EFFECTS ASSOCIATED WITH SIGNIFICANT LOSS OF VASCULAR INTEGRITY: INCREASED VASCULAR LEAKINESS (EDEMA), AN ACTIVATED INFLAMMATORY PHENOTYPE AND EXTENSIVE OXIDATIVE DAMAGE. HOWEVER, DAMAGE TO THE VASCULAR NETWORK UNDER MULTIPLE RADIATION TYPES SIMULTANEOUSLY IS NOT UNDERSTOOD. LIGNAMED WILL EMPLOY GENE KNOCKOUT TECHNOLOGY IN VASCULAR MODELS EXPOSED TO SPACE-RELEVANT MIXED RADIATION REGIMENS TO INVESTIGATE THE INJURY TO THE VASCULATURE. WE HYPOTHESIZE THAT LGM2605 WILL MITIGATE SPACE RADIATION-INDUCED VASCULAR DAMAGE BY INHIBITING EARLY EVENTS THAT CAUSE INFLAMMATION. THIS STUDY WILL CONFIRM THAT 1) SPACE RADIATION DRIVES ENDOVASCULAR DAMAGE VIA ACTIVATION OF THE ENDOTHELIAL INFLAMMATORY PHENOTYPE RESULTING IN INCREASED PERMEABILITY AND 2) WILL VALIDATE LGM2605 AS AN EFFECTIVE MITIGATOR OF SPACE RADIATION-INDUCED VASCULAR DAMAGE BY INHIBITING EARLY EVENTS THAT DRIVE LONG TERM ADVERSE SEQUELLAE.

Dates and value

Award date
Signed on Jun 6, 2017
Potential end of performance
Dec 7, 2017
Current value
$125,000Base and exercised options
Potential value (if all options are exercised)
$125,000

Obligations by fiscal year of action

  • FY2017: $125,000

Total across 1 fiscal year: $125,000

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 6, 2017. View on USAspending · Recipient on SAM.gov

Recipient

LocationPHILADELPHIA, PA
UEIC8L8WEU3TE85
Business sizeSmall businessSize at award, per the contracting officer
Parent companyLIGNAMED, LLC

Business types and certifications

Self-certified small disadvantaged businessFor-profit organizationLimited liability companyPartnership or LLP

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Awarded by
  1. National Aeronautics and Space Administration
  2. NASA SHARED SERVICES CENTER
Funded by
  1. National Aeronautics and Space Administration
  2. NASA SHARED SERVICES CENTER
Funded from
Space technology (DIRECT)Program activities080-0131Federal accounts (agency financial reports)

Place of performance

Place of performance
Philadelphia, Pennsylvania 19104-2853
Congressional district (place of performance)
PA-03As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
500

Contract details

Subcontracting plan
Plan not requiredB
Major program
LGM2605 as a mitigator of space radiation-induced vascular damage
Service Contract Act labor standards
No
Commercial procedures
Commercial item procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Jun 6, 2017Base obligation at award: $125,000
Latest action
Jun 6, 2017 — Base awardModification 0; obligation change +$125,000
Actions by type
  • Base award1
1 actions recorded, Jun 6, 2017 to Jun 6, 2017; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
$125,000
Latest action: change in base and all options
$125,000

Socio-economic and policy

Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Research program (SBIR/STTR)
Small business innovation research program phase i actionSR1
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Purchase orderB
Awarding agency code
8000
Awarding sub-tier code
8000
Contracting office code
80NSSC
Transactions recorded under this award key
1

Funding

Funding agency code
8000
Funding sub-tier code
8000
Funding office code
80NSSC
Treasury accounts
  • 080-2017/2018-0131-000
Object classes
  • 25.5: Research and development contracts